Alex Langford-Smith
Cited by
Cited by
Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB
FL Wilkinson, RJ Holley, KJ Langford-Smith, S Badrinath, A Liao, ...
PloS one 7 (4), e35787, 2012
Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease
M Malinowska, FL Wilkinson, KJ Langford-Smith, A Langford-Smith, ...
PloS one 5 (12), e14192, 2010
Hematopoietic Stem Cell and Gene Therapy Corrects Primary Neuropathology and Behavior in Mucopolysaccharidosis IIIA Mice
A Langford-Smith, FL Wilkinson, KJ Langford-Smith, RJ Holley, ...
Molecular Therapy 20 (8), 1610–1621, 2012
Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model
C Martins, H Hůlková, L Dridi, V Dormoy-Raclet, L Grigoryeva, Y Choi, ...
Brain, 2015
Myeloid/Microglial Driven Autologous Hematopoietic Stem Cell Gene Therapy Corrects a Neuronopathic Lysosomal Disease
A Sergijenko, A Langford-Smith, AY Liao, CE Pickford, J McDermott, ...
Molecular Therapy 21 (10), 1938-1949, 2013
Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress
AM Mahmoud, FL Wilkinson, EM McCarthy, D Moreno-Martinez, ...
The FASEB Journal 31 (10), 4636-4648, 2017
Complementing the sugar code: role of GAGs and sialic acid in complement regulation
A Langford-Smith, AJ Day, PN Bishop, SJ Clark
Frontiers in Immumnology, 2015
The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H?
A Langford-Smith, TDL Keenan, SJ Clark, PN Bishop, AJ Day
Journal of innate immunity 6 (4), 407-416, 2014
Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy
RJ Holley, SM Ellison, D Fil, C O’Leary, J McDermott, N Senthivel, ...
Brain 141 (1), 99-116, 2018
Age and Smoking Related Changes in Metal Ion Levels in Human Lens: Implications for Cataract Formation.
A Langford-Smith, V Tilakaratna, PR Lythgoe, SJ Clark, PN Bishop, ...
PloS one 11 (1), e0147576-e0147576, 2016
Female Mucopolysaccharidosis IIIA Mice Exhibit Hyperactivity and a Reduced Sense of Danger in the Open Field Test
A Langford-Smith, KJ Langford-Smith, SA Jones, RF Wynn, JE Wraith, ...
PloS one 6 (10), e25717, 2011
Endothelial progenitor cells: new targets for therapeutics for inflammatory conditions with high cardiovascular risk
N Edwards, AWW Langford-Smith, FL Wilkinson, MY Alexander
Frontiers in medicine 5, 200, 2018
Hyperactive behaviour in the mouse model of mucopolysaccharidosis IIIB in the open field and home cage environments
A Langford‐Smith, M Malinowska, KJ Langford‐Smith, G Wegrzyn, ...
Genes, Brain and Behavior 10 (6), 673–682, 2011
The interplay of SIRT1 and Wnt signaling in vascular calcification
F Bartoli-Leonard, FL Wilkinson, AWW Langford-Smith, MY Alexander, ...
Frontiers in cardiovascular medicine 5, 183, 2018
Diabetic endothelial colony forming cells have the potential for restoration with glycomimetics
AWW Langford-Smith, A Hasan, R Weston, N Edwards, AM Jones, ...
Scientific reports 9 (1), 1-12, 2019
QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus
N Edwards, AWW Langford-Smith, BJ Parker, IN Bruce, JA Reynolds, ...
Lupus Science & Medicine 5 (1), e000272, 2018
Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrier
KJ Langford-Smith, Z Sandiford, A Langford-Smith, FL Wilkinson, ...
PloS one 8 (10), 2013
Lentiviral Vector Mediated Haematopoietic Stem Cell Gene Therapy For Mucopolysaccharidosis Type IIIA
A Langford-Smith
University of Manchester, 2012
The system can't perform the operation now. Try again later.
Articles 1–18